Efficacy and safety of high dose (≥ 8 mg/kg/day) daptomycin

被引：10
|
作者：
Parra-Ruiz, Jorge [1 ]
Pena-Monje, Alejandro [2 ]
Tomas-Jimenez, Cristina [1 ,3 ]
Pomares-Mora, Jose [4 ]
Hernandez-Quero, Jose [1 ]
机构：
[1] Hosp Univ San Cecilio, Unidad Enfermedades Infecciosas, Granada, Spain
[2] Hosp Univ San Cecilio, Microbiol Serv, Granada, Spain
[3] Hosp Univ Reina Sofia, Med Interna Serv, Murcia, Spain
[4] Hosp Univ San Cecilia, Serv Med Intens, Granada, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2011年 / 29卷 / 06期
关键词：
High dose daptomycin; Efficacy; Safety; SERUM;
D O I：
10.1016/j.eimc.2011.02.012
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Introduction: There is a paucity of data regarding efficacy and safety of high dose (> 8 mg/kg/day) daptomycin. Material and methods: This ambispective study included all patients that received >= 8 mg/kg/day of daptomycin and had efficacy and safety data. Results: Sixty-nine patients were included. Fifty-nine patients (85.5%) were recorded as having been cured or improved. Six patients (8.6%) had a raised CPK during follow-up with no clinical signs of myopathy in any of them. Conclusions: High dose daptomycin shows good efficacy without concerns about toxicity. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：425 / 427
页数：3
相关论文
共 50 条
  • [21] International multicentre observational study to assess the efficacy and safety of a 0.5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid
    Hebert, V.
    Bastos, S.
    Drenovska, K.
    Meijer, J.
    Ingen-Housz-Oro, S.
    Bedane, C.
    Lunardon, L.
    Debarbieux, S.
    Jedlickova, H.
    Caux, F.
    Chaby, G.
    D'Incan, M.
    Feliciani, C.
    Boulard, C.
    Schumacher, N.
    Schmidt, E.
    Roussel, A.
    Richard, M. A.
    Gottlieb, J.
    Ferranti, V.
    Guerin, O.
    Benichou, J.
    Joly, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (06) : 1232 - 1239
  • [22] The efficacy and safety of ziprasidone 80 mg/day and 160 mg/day in schizophrenia and schizoaffective disorder
    Daniel, D
    Reeves, K
    Harrigan, EP
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 204 - 204
  • [23] Standard dosing (3mg/kg/day for 14 days) versus intermittent high dosing (10mg/kg day 1, 5mg/kg days 3 and 6) of liposomal amphotericin B for treating febrile neutropenia: A comparative prospective clinical trial of safety, efficacy and kinetics
    Ellis, M.
    Hedstrom, U.
    Ai-Ramadi, B.
    Alizadeh, H.
    Kristensen, J.
    Kshirsagar, S.
    Blaschke, T.
    Stevens, D. A.
    Klingspor, L.
    Poughias, L.
    PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, : 67 - +
  • [24] Single Dose of 50 mg/kg Clofibrate in Jaundice of Healthy Term Neonates: Randomised Clinical Trial of Efficacy and Safety
    Razieh Fallah
    Zia Islami
    Saeid Reza Lotfi
    The Indian Journal of Pediatrics, 2012, 79 : 194 - 197
  • [25] Single Dose of 50 mg/kg Clofibrate in Jaundice of Healthy Term Neonates: Randomised Clinical Trial of Efficacy and Safety
    Fallah, Razieh
    Islami, Zia
    Lotfi, Saeid Reza
    INDIAN JOURNAL OF PEDIATRICS, 2012, 79 (02): : 194 - 197
  • [26] Comparison of the efficacy and safety of standard- and high-dose daptomycin: A systematic review and meta-analysis
    Samura, Masaru
    Takada, Keisuke
    Hirose, Naoki
    Kurata, Takenori
    Nagumo, Fumio
    Uchida, Masaki
    Inoue, Junki
    Tanikawa, Koji
    Enoki, Yuki
    Taguchi, Kazuaki
    Matsumoto, Kazuaki
    Ueda, Takashi
    Fujimura, Shigeru
    Mikamo, Hiroshige
    Takesue, Yoshio
    Mitsutake, Kotaro
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (04) : 1291 - 1303
  • [27] The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections
    Jugun, Kheeldass
    Vaudaux, Pierre
    Garbino, Jorge
    Pagani, Leonardo
    Hoffmeyer, Pierre
    Lew, Daniel
    Uckay, Ilker
    INTERNATIONAL ORTHOPAEDICS, 2013, 37 (07) : 1375 - 1380
  • [28] The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections
    Kheeldass Jugun
    Pierre Vaudaux
    Jorge Garbino
    Leonardo Pagani
    Pierre Hoffmeyer
    Daniel Lew
    Ilker Uçkay
    International Orthopaedics, 2013, 37 : 1375 - 1380
  • [29] Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy
    Ramon Yuste, Jose
    Quesada, Milena
    Diaz-Rada, Pablo
    Luis Del Pozo, Jose
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 27 : 65 - 66
  • [30] Safety of high-dose daptomycin in patients with severe renal impairment
    Tai, Chih-Hsun
    Shao, Chi-Hao
    Chen, Chen-You
    Lin, Shu-Wen
    Wu, Chien-Chih
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 493 - 499
12345